Showing results (421-430 of 538) with videos related to

Sort By:
Pageof 54
Arthritis Care & Research|July 9, 2016
Severe Health-Related Quality of Life Impairment in Active Primary Sjögren's Syndrome and Patient-Reported Outcomes: Data From a Large Therapeutic TrialDivi Cornec, Valérie Devauchelle-Pensec, Xavier Mariette, et al.
Rheumatology (Oxford, England)|November 22, 2024
Do SMS/e-mail reminders increase influenza vaccination of rheumatoid arthritis patients under anti-TNF: a nested randomized controlled trial in the ART e-cohortYann Nguyen, Gabriel Baron, Naima Hamamouche, et al.
Rheumatology (Oxford, England)|December 23, 2024
Immune checkpoint inhibitors-associated vasculitis: a heterogeneous condition with possible severe disease courseNoemie Chanson, Alexandre Galvagni, Manuel Ramos-Casals, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 18, 2022
A Risk Score to Detect Subclinical Rheumatoid Arthritis-Associated Interstitial Lung DiseasePierre-Antoine Juge, Benjamin Granger, Marie-Pierre Debray, et al.
Autoimmunity Reviews|January 15, 2014
Predictors of early relapse in patients with non-infectious mixed cryoglobulinemia vasculitis: results from the French nationwide CryoVas surveyBenjamin Terrier, Isabelle Marie, David Launay, et al.
Frontiers in Immunology|December 11, 2023
More rapid blood interferon α2 decline in fatal versus surviving COVID-19 patientsCandie Joly, Delphine Desjardins, Raphael Porcher, et al.
RMD Open|November 8, 2018
Sjögren's syndrome: state of the art on clinical practice guidelinesVasco C Romão, Rosaria Talarico, Carlo Alberto Scirè, et al.
Clinical and Experimental Rheumatology|August 30, 2019
Sicca/Sjögren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International ImmunoCancer Registry (ICIR)Manuel Ramos-Casals, Alexandre Maria, María E Suárez-Almazor, et al.
Blood|April 5, 2012
Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas surveyBenjamin Terrier, Evguenia Krastinova, Isabelle Marie, et al.
Joint Bone Spine|December 2, 2023
Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: Results from the international TOCERRA and PANABA observational collaborative studiesKim Lauper, Denis Mongin, Sytske Anne Bergstra, et al.
Pageof 54